Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes

Item
http://www.wikidata.org/entity/Q34301921
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic AgentsThe role of kidney in glucose homeostasis--SGLT2 inhibitors, a new approach in diabetes treatment.Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus.Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 DiabetesThe effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes.Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus.Dapagliflozin for the treatment of type 1 diabetes mellitus.Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male MiceLiraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
P2860

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes

Item
http://www.wikidata.org/entity/Q34301921
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@ast
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@en
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@nl
type
label
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@ast
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@en
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@nl
prefLabel
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@ast
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@en
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Remogliflozin etabonate, a sel ...... se profiles in type 1 diabetes
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932